U.S. FDA approves Lenacapavir
Unitaid welcomes the U.S. Food and Drug Administration’s approval of lenacapavir for HIV prevention – a promising tool that could reshape how those most at risk of infection can protect themselves. A twice-yearly injectable, lenacapavir has the potential to close major gaps in access, particularly for people underserved by existing tools.
[READ MORE]